Calidi Biotherapeutics Inc (CLDI) Stock Price, Quote & News

Company Profile

Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors. It...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 794 9600

Fax: 858 794 9605

Website: www.calidibio.com

Address:

4475 Executive Drive, Suite 200, San Diego, United States

race2zero Jun. 6 at 2:05 AM

$CLDI have a great weekend, next week will be the warmup act to the main event. Reverse split approval on Thursday, announced on Friday. A 20-40% drop, cash in, roll it all over on the split for an easy 70-80% in a matter of days. Come short w us and destroy this POS

1 · Reply

race2zero Jun. 5 at 11:16 PM

$CLDI aren’t you tired of looking like a complete moron?

0 · Reply

QQQ_Guy Jun. 5 at 11:15 PM

$CLDI this will pump to 1.00 Monday.

0 · Reply

race2zero Jun. 5 at 8:58 PM

$CLDI by this time next Friday, you’ll have confirmation that your shares are going to be divided by 16🤣🤣🤣🤣 enjoy!

0 · Reply

race2zero Jun. 5 at 7:48 PM

$CLDI I wonder where @Spy_Guy and @QQQ_Guy have been today. Without them there isn’t a single bullish person for this POS scam.

0 · Reply

race2zero Jun. 5 at 4:11 PM

$CLDI and it’s only going to get worse. Some major short catalysts coming up quickly

0 · Reply

ka1954 Jun. 5 at 3:35 PM

$CLDI where was this fucking stock when market went up 20% from recent lows? it was going down, and now it pretends to go down more when market in crash mode

0 · Reply

race2zero Jun. 5 at 3:30 PM

$CLDI another opportunity for @Spy_Guy to unload for a loss in the .15s

0 · Reply

race2zero Jun. 5 at 1:40 PM

$CLDI never gets old! I’m going to miss this after the reverse split and I retire after shorting this to zero

0 · Reply

race2zero Jun. 5 at 12:54 PM

$CLDI next Thursday the voting ends and the reverse split will be announced on Friday and that’s all she wrote boys….short fairly small until then, pick it up a bit for the announcement of the voting results and then all in on the split. Destroy this POS scam once and for all

0 · Reply

Calidi announces online abstract acceptances at 2026 ASCO Meeting

May 26, 2026, 8:00 AM EDT - 12 days ago

Calidi Biotherapeutics Announces Online Abstract Acceptances at the 2026 ASCO Annual Meeting

2026-05-22T22:05:57.000Z - 15 days ago

Calidi provides required NYSE American disclosure

May 22, 2026, 6:00 PM EDT - 15 days ago

Calidi Biotherapeutics Provides Required NYSE American Disclosure

May 14, 2026, 4:10 PM EDT - 24 days ago

Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights

May 13, 2026, 8:00 AM EDT - 25 days ago

Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston

Apr 29, 2026, 8:00 AM EDT - 5 weeks ago

Calidi Biotherapeutics Announces Strategic Partnership with TransferAI to Drive Efficiencies in the IND Submission Process for CLD-401 Using Agentic AI

2026-04-21T13:29:48.000Z - 6 weeks ago

Calidi presents new data on CLD-401 at AACR

2026-04-20T12:54:38.000Z - 6 weeks ago

Calidi presents new data on in situ t-cell engagers at AACR

Apr 20, 2026, 8:00 AM EDT - 6 weeks ago

Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Mar 27, 2026, 4:25 PM EDT - 2 months ago

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Operational Highlights

2026-03-12T12:17:48.000Z - 3 months ago

Calidi presents manufacturing process for CDI-401 at BioProcessing Summit

Mar 12, 2026, 8:00 AM EDT - 3 months ago

Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company's Approach to Manufacturing

Mar 9, 2026, 8:50 PM EDT - 3 months ago

Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

2026-03-06T13:35:48.000Z - 3 months ago

Calidi prices 10.5M units at 50c in underwritten public offering

Mar 6, 2026, 8:30 AM EST - 3 months ago

Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering

2026-03-05T23:00:46.000Z - 3 months ago

Calidi announces offering of units, no amount given

Mar 5, 2026, 5:57 PM EST - 3 months ago

Calidi Biotherapeutics Announces Proposed Public Offering

2026-02-20T13:11:19.000Z - 3 months ago

Calidi presents data on novel approach to use of BiTEs

Feb 20, 2026, 8:00 AM EST - 3 months ago

Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference

2026-02-12T13:10:13.000Z - 4 months ago

Calidi to present on approach to bispecific T-cell engagers using RedTail

Feb 12, 2026, 8:00 AM EST - 4 months ago

Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference

2026-01-28T13:13:01.000Z - 4 months ago

Calidi announces 2026 milestones

Nov 17, 2025, 8:00 AM EST - 7 months ago

Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025

Nov 13, 2025, 4:15 PM EST - 7 months ago

Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights

2025-11-10T13:20:35.000Z - 7 months ago

Calidi presents new data on CLD-401 at 2025 SITC annual meeting

2025-10-30T12:15:32.000Z - 7 months ago

Calidi announces new data to be presented on CLD-401 at 2025 SITC meeting

2025-10-22T12:11:42.000Z - 8 months ago

Calidi announces formation of its Scientific Advisory Board

Aug 21, 2025, 6:33 PM EDT - 10 months ago

Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

2025-08-20T13:20:27.000Z - 10 months ago

Calidi prices 1.47M units at $2.00 in underwritten public offering

Aug 20, 2025, 9:15 AM EDT - 10 months ago

Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering

Aug 8, 2025, 4:15 PM EDT - 10 months ago

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

2025-08-05T13:46:30.000Z - 10 months ago

Calidi Biotherapeutics Inc trading resumes

2025-08-05T13:43:07.000Z - 10 months ago

Calidi Biotherapeutics Inc trading halted, volatility trading pause

2025-07-29T12:22:15.000Z - 11 months ago

Calidi receives FDA Fast Track designation for CLD-201

2025-07-25T20:50:25.000Z - 11 months ago

Calidi announces 1-for-12 reverse stock split

Jul 25, 2025, 4:45 PM EDT - 11 months ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

Jul 22, 2025, 8:00 AM EDT - 11 months ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on July 24

Jul 10, 2025, 8:30 AM EDT - 11 months ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment

Jul 9, 2025, 2:01 PM EDT - 11 months ago

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds

Jul 8, 2025, 8:30 AM EDT - 11 months ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment

Jun 27, 2025, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Shareholder Letter from CEO

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

Apr 16, 2025, 9:30 AM EDT - 1 year ago

Global X Offers Precise U.S. Equity Exposure with Launch of Domestic Focused Funds

EGLE

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 28, 2025, 9:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 10, 2025, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform

Feb 28, 2025, 9:00 AM EST - 1 year ago

Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

OSTX

Feb 24, 2025, 8:00 AM EST - 1 year ago

Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital

Jan 29, 2025, 8:00 AM EST - 1 year ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 5

Jan 28, 2025, 8:00 AM EST - 1 year ago

Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement

Jan 10, 2025, 4:30 PM EST - 1 year ago

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

Jan 10, 2025, 8:30 AM EST - 1 year ago

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

Nov 15, 2024, 4:05 PM EST - 1 year ago

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

Nov 14, 2024, 8:30 AM EST - 1 year ago

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

Nov 12, 2024, 5:29 PM EST - 1 year ago

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Oct 25, 2024, 9:00 AM EDT - 1 year ago

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

NXL

Oct 24, 2024, 8:30 AM EDT - 1 year ago

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

Oct 23, 2024, 8:31 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Oct 18, 2024, 11:00 PM EDT - 1 year ago

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)

Oct 18, 2024, 8:45 AM EDT - 1 year ago

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

GRRR

Aug 13, 2024, 5:37 PM EDT - 1 year ago

Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

Aug 2, 2024, 9:00 AM EDT - 2 years ago

GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Jul 29, 2024, 9:00 AM EDT - 2 years ago

Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

Jul 18, 2024, 8:00 AM EDT - 2 years ago

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform

race2zero Jun. 6 at 2:05 AM

1 · Reply

race2zero Jun. 5 at 11:16 PM

$CLDI aren’t you tired of looking like a complete moron?

0 · Reply

QQQ_Guy Jun. 5 at 11:15 PM

$CLDI this will pump to 1.00 Monday.

0 · Reply

race2zero Jun. 5 at 8:58 PM

$CLDI by this time next Friday, you’ll have confirmation that your shares are going to be divided by 16🤣🤣🤣🤣 enjoy!

0 · Reply

race2zero Jun. 5 at 7:48 PM

$CLDI I wonder where @Spy_Guy and @QQQ_Guy have been today. Without them there isn’t a single bullish person for this POS scam.

0 · Reply

race2zero Jun. 5 at 4:11 PM

$CLDI and it’s only going to get worse. Some major short catalysts coming up quickly

0 · Reply

ka1954 Jun. 5 at 3:35 PM

$CLDI where was this fucking stock when market went up 20% from recent lows? it was going down, and now it pretends to go down more when market in crash mode

0 · Reply

race2zero Jun. 5 at 3:30 PM

$CLDI another opportunity for @Spy_Guy to unload for a loss in the .15s

0 · Reply

race2zero Jun. 5 at 1:40 PM

$CLDI never gets old! I’m going to miss this after the reverse split and I retire after shorting this to zero

0 · Reply

race2zero Jun. 5 at 12:54 PM

0 · Reply

race2zero Jun. 5 at 12:16 PM

$CLDI hey @Spy_Guy are you finally going to give us a reason you think this is a $5 stock? This stock has killed you so far

0 · Reply

race2zero Jun. 4 at 11:54 PM

$CLDI @QQQ_Guy and @Spy_Guy can you two get your shit together, you’re only two bulls

0 · Reply

race2zero Jun. 4 at 11:48 PM

$CLDI welcome back

0 · Reply

race2zero Jun. 4 at 11:48 PM

$CLDI $PFE they could buy the entire float for about $3 million right now… Or they could just wait 6 to 9 more months if they really wanted it and get it on the clearance liquidation aisle after they go bankrupt

0 · Reply

QQQ_Guy Jun. 4 at 11:08 PM

$CLDI $PFE Pfizer could buy this company and we will all be rich. Price target .67

0 · Reply

Spy_Guy Jun. 4 at 10:27 PM

$CLDI this is a $5 stock

1 · Reply

knw Jun. 4 at 7:46 PM

$CLDI weeee those cheapies are paying 🤘🏻

0 · Reply

race2zero Jun. 4 at 6:28 PM

$CLDI that was @Spy_Guy that dumped those huge lots in the .15s two days ago…huge loss!

0 · Reply

race2zero Jun. 4 at 2:59 PM

$CLDI congrats! You are the only person in the history of this to be green. Better sell while you can

2 · Reply

race2zero Jun. 4 at 2:40 PM

$CLDI will you be joining us by shorting big time after the reverse split to destroy this company once and for all?

1 · Reply

knw Jun. 4 at 2:40 PM

$CLDI I added those cheapies now .16 avg and im green weeee🤘🏻

0 · Reply

race2zero Jun. 4 at 2:38 PM

$CLDI Poma looks like he belongs in a “special” home and he rode the short bus to school

0 · Reply

Market Cap	3.26M
Revenue (ttm)	0.00
Net Income (ttm)	-19.91M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.12

Volume	1,503,500
Avg Vol	5,579,864
Day's Range	N/A - N/A
Shares Out	19.31M
Stochastic %K	28%
Beta	1.31
Analysts	Strong Buy
Price Target	$10.00